The rising interest in GLP-1 agonists for diabetes has generated a discussion about delivery routes : skin-applied devices versus tablets . Usually , GLP-1 treatments were exclusively available in tablet https://martinatzas093838.techionblog.com/41192987/glp-1-skin-applications-vs-oral-medications-is-best-for-individuals